Endocyte Announces Updated Data on EC1456 and EC1169 at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting
May 13, 2015 17:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., May 13, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT) a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion...
Endocyte Reports First Quarter 2015 Financial Results and Provides Update on Clinical Progress
May 07, 2015 16:01 ET
|
Endocyte, Inc.
- Dose Escalation for EC1456 and EC1169 Move to Fifth Dosing Cohorts Evaluating Two Schedules for Each Agent -
- Conference Call Today at 4:30 p.m. EDT -
WEST LAFAYETTE, Ind., May 7, 2015 (GLOBE...
Endocyte Announces First Quarter 2015 Earnings Conference Call
April 30, 2015 16:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., April 30, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc., (Nasdaq:ECYT) announced today that the company will host a conference call on Thursday, May 7, at 4:30 p.m. EDT to discuss its...
Endocyte Announces Presentations at American Association for Cancer Research (AACR) 2015 Annual Meeting
April 10, 2015 08:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., April 10, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and...
Endocyte Appoints P. David Mozley, M.D. as Vice President of Imaging
April 07, 2015 16:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., April 7, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT) a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion...
Endocyte to Present at the 2015 Annual Meeting on Women's Cancer for the Society of Gynecologic Oncology (SGO)
March 20, 2015 08:00 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., March 20, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT) a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion...
Endocyte Reports Fourth Quarter and Year End 2014 Financial Results and Provides Clinical Update
March 02, 2015 08:00 ET
|
Endocyte, Inc.
Dose Escalation Continues for EC1456 and EC1169 as Endocyte Outlines Plans for Expansion of the Trials in Targeted Patients Once Maximum Doses Are Determined
Conference Call Today at 8:30 a.m....
Endocyte to Present Data on EC1456 and EC1169 at the International Congress on Targeted Anticancer Therapies in Paris
February 27, 2015 23:18 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., Feb. 27, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion...
Endocyte Announces Fourth Quarter and Full Year 2014 Earnings Conference Call
February 23, 2015 16:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc., (Nasdaq:ECYT) announced today that the company will host a conference call on Monday, March 2, at 8:30 a.m. EST to discuss its...
Endocyte to Present at Upcoming Conferences
February 17, 2015 16:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., Feb. 17, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...